![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CryoLife Agrees to Buy On-X
CryoLife Agrees to Buy On-X
![CryoLife_Logo.jpg](https://www.fdanews.com/ext/resources/test/Device_Images5/CryoLife_Logo.jpg?t=1576044051&width=430)
Cardiac and vascular surgery company CryoLife has entered into an agreement to acquire Austin, Texas-based On-X Life Technologies Holdings. The deal is expected to close next month.
CryoLife will pay $130 million upfront for On-X, which is a player in the mechanical valve market. On-X was founded in 1994 as the Medical Carbon Research Institute and scored PMA approval for its On-X prosthetic heart valve in 2002. It changed its name to On-X in 2007.
On-X generated revenue of approximately $33 million in 2014, according to CryoLife. — Elizabeth Hollis
Upcoming Events
-
21Oct